Childhood cancer survivors are at risk for long-term peripheral neuropathy, particularly when treated with cisplatin.
Chronic pain following adjuvant chemotherapy with docetaxel or oxaliplatin may be solely account for by pure sensory neuropathy.
Multivitamin use before diagnosis of breast cancer is associated with reduced risk of symptoms of chemotherapy-induced peripheral neuropathy.
Results from the ASCEND study recently published in BioMed Central Neurology indicate that an 8% capsaicin patch is effective in relieving peripheral neuropathic pain resulting from a wide range of etiologies.
Mindfulness practice during chemotherapy can reduce the blunting of neuroendocrine profiles typically observed in cancer patients.
Clinical Pain Advisor Articles
- Rapid Fentanyl Test Strips Accepted by Young Adult Drug Users
- Updated Evidence-Based Recommendations for Buprenorphine Treatment
- Pain Acceptance May Reduce Headache-Related Disability in Migraine
- Central Sensitization in Greater Trochanteric Pain Syndrome
- FDA Issues Safety Alert Regarding Intrathecal Delivery of Pain Meds
- The Unintended Consequences of the CDC Opioid Guideline According to Pain Management Specialists
- FDA-Approved Test Provides Pharmacogenetic Reports Directly to Consumers
- Set of Interventions May Effectively Reduce Opioid Overprescribing
- Two Screening Tools May Accurately Predict Transition From Acute to Chronic Low Back Pain
- Long Wait Times Between Referral and Interdisciplinary Pediatric Chronic Pain Evaluation